ストックスクリーナーアプリを入手
21.39
2.00%
0.42
前日終値:
$20.97
開ける：
$21.31
24時間の取引高:
1.53M
Relative Volume:
0.74
時価総額：
$1.45B
収益：
$796.00M
当期純損益:
$-136.49M
株価収益率:
-10.23
EPS:
-2.09
ネットキャッシュフロー:
$-64.24M
1週間 パフォーマンス:
+2.25%
1か月 パフォーマンス:
+18.44%
6か月 パフォーマンス:
+2.25%
1年 パフォーマンス:
-37.66%
1日の値動き範囲:
$20.56
$21.68
1週間の範囲:
$20.20
$22.09
52週間の値動き範囲:
$9.98
$38.28
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
名前
Tandem Diabetes Care Inc
セクター
電話
858-366-6900
住所
12400 HIGH BLUFF DRIVE, San Diego, CA
TNDM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
21.39 | 1.42B | 796.00M | -136.49M | -64.24M | -2.09 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-21 | 再開されました | Stifel | Hold |
| 2025-09-08 | 開始されました | Oppenheimer | Outperform |
| 2025-08-12 | アップグレード | Citigroup | Sell → Neutral |
| 2025-08-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | ダウングレード | Citigroup | Neutral → Sell |
| 2025-06-16 | 開始されました | Truist | Hold |
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2025-03-05 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-03-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-10-04 | 開始されました | Goldman | Neutral |
| 2024-10-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-22 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-04-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | アップグレード | Stifel | Hold → Buy |
| 2023-08-04 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-05-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-04-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-15 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-08-09 | ダウングレード | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 開始されました | Wells Fargo | Overweight |
| 2020-07-31 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-06-18 | 繰り返されました | Raymond James | Outperform |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-06 | 開始されました | Raymond James | Outperform |
| 2020-02-04 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 開始されました | Guggenheim | Buy |
| 2019-10-04 | アップグレード | UBS | Neutral → Buy |
| 2019-05-17 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-13 | 開始されました | SVB Leerink | Outperform |
| 2019-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2019-03-05 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-02-27 | 繰り返されました | Lake Street | Buy |
| 2018-11-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 繰り返されました | Dougherty & Company | Buy |
| 2018-09-26 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Tandem Diabetes Care Inc (TNDM) 最新ニュース
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Don't Buy Tandem Diabetes Care Until This Big Thing Happens - AOL.com
(TNDM) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors t - GuruFocus
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action InvestigationTNDM - PR Newswire
Tandem Diabetes Care (TNDM) Sees Target Price Raised by Citigrou - GuruFocus
Tandem Diabetes Care (NASDAQ:TNDM) Has Debt But No Earnings; Should You Worry? - 富途牛牛
TNDM Investor News: If You Have Suffered Losses in Tandem - GlobeNewswire
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now - TradingView
Did Tandem’s Insulin Pump Correction and Securities Probe Just Shift Tandem Diabetes Care's (TNDM) Investment Narrative? - Sahm
Tandem Diabetes Care Appoints Sandra Beaver to Board - MSN
How Tandem Diabetes Care Inc. stock valuations compare to rivalsTrade Entry Report & Free Daily Entry Point Trade Alerts - Newser
Is Tandem Diabetes Care Inc. (TD5A) stock resilient in recession scenariosJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Taking Stock of Tandem Diabetes Care (TNDM) Valuation After Fresh Analyst Upgrades and Reaffirmed Optimism - Sahm
DelveInsight expects the Artificial Pancreas Device Market to grow at a CAGR of 16.33% through 2032 - The Globe and Mail
Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know - Finviz
Will Tandem Diabetes Care Inc. (TD5A) stock outperform value peersTrade Analysis Report & Growth Oriented Trade Recommendations - Newser
Tandem Diabetes Care Stock Gains After Analyst Raises Target to $23News and Statistics - IndexBox
Why Tandem Diabetes Care Inc. (TD5A) stock could be top winnerM&A Rumor & Safe Entry Zone Identification - Newser
TNDM SEC FilingsTandem Diabetes 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Tandem Diabetes Care’s (TNDM) Valuation After Legal Probe and t:slim X2 Pump Correction Announcement - Yahoo Finance
TNDM: Morgan Stanley Raises Price Target Amidst Maintained Ratin - GuruFocus
How Tandem Diabetes Care Inc. (TD5A) stock reacts to Fed tightening2025 AllTime Highs & Low Drawdown Investment Strategies - Newser
Free cash flow per share of Tandem Diabetes Care, Inc. – LSE:0M0F - TradingView
(TNDM) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
How Recent Product Correction and Legal Inquiry May Impact Tandem Diabetes Care’s (TNDM) Investment Outlook - Sahm
Risk Check: What makes Tandem Diabetes Care Inc. (TD5A) stock appealing to growth investorsQuarterly Trade Summary & Weekly High Return Forecasts - moha.gov.vn
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
What risks investors should watch in Tandem Diabetes Care Inc. stockPortfolio Update Report & Verified Short-Term Plans - BỘ NỘI VỤ
A Fresh Look at Tandem Diabetes Care (TNDM) Valuation Following Insulin Pump Device Correction News - Sahm
[Form 4] TANDEM DIABETES CARE INC Insider Trading Activity - Stock Titan
[Form 3] TANDEM DIABETES CARE INC Initial Statement of Beneficial Ownership - Stock Titan
Implantable Insulin Pumps Market Size to Hit USD 14.27 Billion by 2034 - Precedence Research
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), ... - Bakersfield.com
Tandem Diabetes Care Shows Market Leadership With Jump To 83 RS Rating - MSN
Why Tandem Diabetes Care (TNDM) Is Up 14.3% After FDA Clears Android App for Mobi System and What’s Next - Sahm
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Yahoo Finance
Tandem Diabetes Care, Inc.Common Stock (NQ: TNDM - Markets Financial Content
Momentum Stocks November 2025: Tandem Diabetes Sell, Vicor & Cardinal Health BuyNews and Statistics - IndexBox
Why Tandem Diabetes Care Inc. stock is trending among retail tradersTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Is Tandem Diabetes Care Inc. (TD5A) stock a momentum leaderLayoff News & Verified Momentum Stock Alerts - newser.com
Why millennials buy Tandem Diabetes Care Inc. (TD5A) stockJuly 2025 Gainers & Consistent Income Trade Ideas - newser.com
Barclays Reaffirms Their Buy Rating on Tandem Diabetes Care (TNDM) - The Globe and Mail
Can Tandem Diabetes Care Inc. stock deliver surprise earnings beatQuarterly Performance Summary & Daily Chart Pattern Signals - newser.com
(TNDM) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Tandem Diabetes Care Inc (TNDM) 財務データ
収益
当期純利益
現金流量
EPS
Tandem Diabetes Care Inc (TNDM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sheridan John F | PRESIDENT & CEO |
Nov 17 '25 |
Option Exercise |
0.00 |
11,454 |
0 |
120,638 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Nov 17 '25 |
Option Exercise |
0.00 |
2,599 |
0 |
3,587 |
| Carpenter Rick | Chief Technology Officer |
Nov 17 '25 |
Option Exercise |
0.00 |
2,334 |
0 |
24,509 |
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Nov 17 '25 |
Option Exercise |
0.00 |
76 |
0 |
32,424 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Nov 17 '25 |
Option Exercise |
0.00 |
2,999 |
0 |
38,184 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Nov 17 '25 |
Option Exercise |
0.00 |
3,063 |
0 |
21,867 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Oct 15 '25 |
Option Exercise |
0.00 |
3,636 |
0 |
23,685 |
| Carpenter Rick | Chief Technology Officer |
Sep 15 '25 |
Option Exercise |
0.00 |
406 |
0 |
22,773 |
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Sep 15 '25 |
Option Exercise |
0.00 |
7,415 |
0 |
36,214 |
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Aug 15 '25 |
Option Exercise |
0.00 |
76 |
0 |
28,839 |
0.52%
0.28%
大文字化:
|
ボリューム (24 時間):